跳至主要内容
临床试验/CTRI/2024/04/066570
CTRI/2024/04/066570已完成2 期

Efficacy Of Homoeopathic Medicines Using LM Potency in Management Of Essential Hypertension(Grade 1) in Patients having Body Mass Index 25-35

DrArfana Chauhan1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2024年5月6日最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
40
试验地点
1
主要终点
changes in the blood pressure both systolic and diastolic

研究概览

简要总结

This study is a prospective pre test post test interventional trial to assess the efficacy of Homoeopathic medicines in LM potency in 40 participants of grade 1 hypertension BMI 25-35 as per the inclusion criteria and exclusion criteria from OPD The Primary outcome will assess the changes in Blood pressure after giving Individual Homoeopathic medicines in LM potency  at 2 4 6 8  months.

Secondary outcome will assess changes in MINICHAL Questionnarie after giving Individual Homoeopathic medicines in LM potency from baseline and at the end of treatment .

研究设计

研究类型
Interventional
分配方式
Na
盲法
Participant Blinded

入排标准

年龄范围
30.00 Year(s) 至 79.00 Year(s)(—)
性别
All

入选标准

  • Participants must have a confirmed diagnosis of essential hypertension as per established medical criteria Participants with baseline Systolic Blood Pressure more than 120 to 159 and Diastolic Blood Pressure more than 80 to 99 who are not on any anti hypertensive medicines Participants with a body mass index of 25 to 35 Participants willing to provide informed consent to participate in the study and also who can fill up the Questionnaire.

排除标准

  • Patients who are suffering from secondary Hypertension of known aetiology such as renal disease pheochromocytoma or Cushing’s syndrome known diabetics, history of myocardial infarction severe coronary artery disease or clinically significant heart failure or valvular defect or known cases of cardiac diseases any systemic illness consumptive disease autoimmune disease cancer hepatic disease renal disease Patients receiving any drugs known to affect Blood Pressure or medical treatments that can influence the Blood Pressure having a history of alcohol or drug abuse Women who are taking contraceptive pills pregnancy and lactating mother Patients having class 2 and class 3 obesity.

结局指标

主要结局

changes in the blood pressure both systolic and diastolic

时间窗: data will be assessed from baseline 2 4 6 8 months and changes in the blood pressure will be assessed

次要结局

  • changes in the Minichal Questinnorie score(from baseline to at the end of treatment)

研究者

发起方
DrArfana Chauhan
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

DrArfana Chauhan

Smt A J Savla Homoepathic Medical college and Research Institute

研究点 (1)

Loading locations...

相似试验